AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
2 Top Dividend Stocks to Buy Hand Over Fist
Every company faces headwinds eventually. The top ones know how to bounce back.
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
These businesses can pack a punch in your portfolio over the long run.
Better Dividend Growth Stock: AbbVie or Amgen?
A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy.
Is AbbVie Stock a Buy Now?
Some would say the growth story is over, but that view might be a bit myopic.
3 Dividend Stocks That Are No-Brainer Buys Right Now
These stocks check off multiple boxes for investors.
Is AbbVie Stock a Buy Now?
Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.
9 Best Index Funds for Long-Term Investors
Here are the nine best index funds to add to your portfolio for steady, low-cost growth.
Dividend Kings of 2024
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
Valuation
Earnings Transcripts
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2023.
AbbVie (ABBV) Q3 2023 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2023.
AbbVie (ABBV) Q2 2023 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2023.
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.